853058-41-0

Basic information

• Product Name: ETHYL 4,5-DIHYDRO-4-OXO-1H-PYRROLO[3,2-D]PYRIMIDINE-7-CARBOXYLATE
• Synonyms: ETHYL 4,5-DIHYDRO-4-OXO-1H-PYRROLO[3,2-D]PYRIMIDINE-7-CARBOXYLATE;Ethyl 4-hydroxy-5H-pyrrolo[3,2-d]pyriMidine-7-carboxylate;4,5-Dihydro-4-oxo-1H-pyrrolo[3,2-d]pyrimidine-7-carboxylic acid ethyl ester;Ethyl 4-oxo-4,5-dihydro-1H-pyrrolo[3,2-d]pyriMidine-7-carboxylate;ethyl 4-oxo-4,5-dihydro-3H-pyrrolo[3,2-d]pyriMidine-7-carboxylate;ethyl 4,5-dihydro-4-oxo-3H-pyrrolo[3,2-d]pyrimidine-7-carboxylate;4-Hydroxy-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic acid ethyl ester
• CAS NO: 853058-41-0
• Molecular Formula: C₉H₉N₃O₃
• Molecular Weight: 207.19
• Mol File: 853058-41-0.mol

Chemical Properties

• Appearance: /
• Density: 1.53±0.1 g/cm3 (20 ºC 760 Torr)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: ETHYL 4,5-DIHYDRO-4-OXO-1H-PYRROLO[3,2-D]PYRIMIDINE-7-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 4,5-DIHYDRO-4-OXO-1H-PYRROLO[3,2-D]PYRIMIDINE-7-CARBOXYLATE(853058-41-0)
• EPA Substance Registry System: ETHYL 4,5-DIHYDRO-4-OXO-1H-PYRROLO[3,2-D]PYRIMIDINE-7-CARBOXYLATE(853058-41-0)

Safety Data

• Hazardous Substances Data: 853058-41-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
ETHYL 4,5-DIHYDRO-4-OXO-1H-PYRROLO[3,2-D]PYRIMIDINE-7-CARBOXYLATE is used as a key intermediate in the synthesis of novel drug candidates due to its potential to contribute to the development of new therapeutic agents.
Used in Chemical Research:
In the field of chemical research, ETHYL 4,5-DIHYDRO-4-OXO-1H-PYRROLO[3,2-D]PYRIMIDINE-7-CARBOXYLATE serves as a valuable building block for the creation of bioactive compounds, facilitating the exploration of its chemical properties and reactivity in various synthetic pathways.
Used in Medicinal Chemistry Studies:
ETHYL 4,5-DIHYDRO-4-OXO-1H-PYRROLO[3,2-D]PYRIMIDINE-7-CARBOXYLATE is utilized as a subject of study in medicinal chemistry to understand its interactions with biological targets and its potential role in the treatment of various diseases, leveraging its unique structural features and functional groups.

InChI:InChI=1S/C9H9N3O3/c1-2-15-9(14)5-3-10-7-6(5)11-4-12-8(7)13/h3-4,10H,2H2,1H3,(H,11,12,13)

Upstream product

• 42466-67-1 ethyl (ethoxymethylene)cyanoacetate 
• 3473-63-0 formamidine acetic acid 
• 13433-00-6 diethyl aminomalonate hydrochloride 
• 853058-40-9 diethyl 3-amino-1H-2,4-pyrroledicarboxylate 

Downstream Products

• 853058-42-1 4-chloro-5H-pyrrolo[3,2-d]pyrimidine-7-carboxylic acid ethyl ester 

Relevant articles and documents

HETEROBICYCLIC MATRIX METALLOPROTEASE INHIBITORS

The present invention relates generally to amide containing heterobicyclic containing pharmaceutical agents, and in particular, to amide containing heterobicyclic metalloprotease inhibiting compounds. More particularly, the present invention provides a new class of heterobicyclic MMP-3 and/or MMP-13 inhibiting compounds, that exhibit an increased potency and selectivity in relation to currently known MMP-13 and MMP-3 inhibitors.

Diazaindole-dicarbonyl-piperazinyl antiviral agents

The invention comprises substituted diazaindole-dicarbonyl-piperazinyl derivatives of general Formula I wherein: Q is selected from the group consisting of — may represent a bond; T is —C(O)— or —CH(CN)—; and —Y— is selected from the group consisting of compositions thereof and their use for treating HIV infection.